You are here

Coronavirus (COVID-19): Information on medicines and medical devices

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page.

Please read the information below before contacting the TGA to see if your question is already answered.

8 December 2021
On 9 August 2021 the TGA granted provisional approval to Moderna Australia Pty Ltd for its COVID-19 vaccine - SPIKEVAX (elasomeran) - making it the fourth COVID-19 vaccine to receive regulatory approval in Australia.
8 December 2021

COVID-19 vaccines undergoing evaluation for provisional registration by the TGA

5 December 2021

The TGA has provisionally approved a booster dose of the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for individuals 18 years and older.

25 November 2021
A list of disinfectant products included in the ARTG with specific claims against SARS-Cov-2 (COVID 19) or COVID-19 on the product label.
22 November 2021
The TGA has granted a number of provisional determinations in relation to COVID-19 vaccines.
8 November 2021
Information for advertisers and consumers relating to ads for therapeutic goods that claim to treat or prevent COVID-19, including specific advertising requirements and consequences for non-compliance
8 November 2021
Updated guidance clarifying the interaction between TGA and AHPRA advertising guidelines.
1 November 2021

COVID-19 vaccine batch release information is now available.

14 October 2021

Find information about advertising COVID-19 rapid tests.

24 September 2021
Frequently asked questions for new sponsors in relation to the supply of disinfectant products.

Pages

Further information

Contact TGA Info

Tel: 1800 020 653
Email: info@tga.gov.au

Note: we are currently experiencing a high volume of calls and emails. Please bear with us as we try to respond to queries as quickly as possible.

Department of Health

Coronavirus (COVID-19) health alert — for information and advice not specific to therapeutic goods.

Follow us